Imagine if losing weight were as simple as swallowing a daily pill-no needles, no injections and no anxiety. If you're among ...

As a work of reportage, Off the Scales does a wonderful job of explaining the origins of Ozempic and other GLP-1 drugs and ...

Eli Lilly and Company’s LLY stock has been consistently trading above its 50-day and 200-day simple moving averages (SMAs) ...

The blockbuster drug, marketed globally by Novo Nordisk as Ozempic for Type 2 diabetes and for obesity, has been at the ...

Some experts cited the case of Slentrol, an older weight loss drug for dogs made by Pfizer’s animal health division (which ...

Coming from the same manufacturers of Mounjaro, this latest jab making waves is believed to be up to three times stronger ...

A first-of-its-kind oral drug boosts muscle metabolism to improve blood sugar and body composition is now headed into larger ...

Medicare beneficiaries spent $1.7 billion out of pocket on the 15 drugs. The negotiated price reductions may save beneficiaries $685 million in out-of-pocket costs.

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results. Will dialysis and organ transplants become a thing of the past? A healthy ...

A competitive drug market strongly encourages companies to best their rivals by developing the next generation of life-saving therapies.